% | $
Quotes you view appear here for quick access.

Echo Therapeutics, Inc. Message Board

  • huntleypalmer2003 huntleypalmer2003 Jan 22, 2013 12:42 PM Flag

    Are The Results Positive?

    The poster session presentation is being hyped by the company as the second coming. The infomation that was presented was nothing new. And the market is telling us that as well. Other than some premarket and early interest whick took the stock as high as $1.45 the stock is down into the$1. 20's on selling. So, where do we go from here? I wonder if those with expertise in the deveopment of the ecte glucose detection system see something that is not positive? Or since nothing new was presented are we back to square one with a 12-18 month horizon before hoped for FDA approval?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Okay great products and great stock prices are mostly not tied to the hip.

      FACT; Since 2005 ECTE has lost investors money... Drip drip drip...

      AT the same time pharmaceutical and biotech stocks like REGN, CELG, ARNA, ALNY, DYAX, ACAD many tens of others have been cooking mega profits for investors.

      Why bother with ECTE in the hopes that somehow the market reward you for being patient.

      Even a broken clock is correct twice in a day but what about the other 23 hours and 58 minutes of the day.

      No need to romanticize a stock - I thought the objective was to make money in the here and now.

      Consider That Only One Site Picked 3 Of The Top 6 US Stocks In 2012, Including The Absolute #1 Top Gaining US Stock In Each Of The Following Years; 2003, 2004, 2005...

      ►:m:u:a:t:h:e: . :c:o:m: (without the colons).

      Take a look at these recent winners; IMH [+800%], CLSN [+710%], ARNA [+591%](could breakout above $10 eventually - wow!), CONN [+442%], BLDR [+380%], INFI [+416%], PHM [+367%], DDD [+300%], ELLI [+417%], SNTS [+266+], HOV [+242%], REGN [+245%] RPRX [+400%], CVI [+546% - since Summer 2010], WNR [+675% - since Summer 2010], on and on...

    • I first learned about echo at the beginning of the decade. I rode them down from around $10 and gave up but I always thought they were a good bio without a good product. Maybe they'll get their justice this year. This non-invasive monitoring is a wonderful technology IMHO.

      • 1 Reply to tooncat222
      • It's a huge breakthrough. The technology will improve over time - but this is good enough to make investors very happy. The results weren't just good, they were through the roof.

        But as an investor in small cap biotechs, I know that patience and timing are important. So I don't know if we'll go lower from here. We may or may not. But even if we do, I am expecting EU approval and to see the stock price as a minimum of $3 per share in 2013. Hopefully much more.

        Sentiment: Strong Buy

    • I think that it has come down to everyone is waiting and acquiring slowly. The excitement of a buyout or things of that sort have not been present. The team is in place, the product is about ready, the plan is in place, but the game hasn't started yet. I think that when it does, it will move so fast that anyone that is not on the field will not have much of a chance. Patience is the key here. I acquire on pullbacks and wait. Yes, waiting is hard


      Sentiment: Buy

    • Don't wait for FDA approval which will take time. Near term catalyst is EU approval and even before that clarity on what is needed for that approval. Since all that is within the next 3 quarters the stock is already showing life.

1.63+0.01(+0.62%)May 27 4:00 PMEDT